Randomized controlled trial of behavioral activation smoking cessation treatment for smokers with elevated depressive symptoms.
about
Additional behavioural support as an adjunct to pharmacotherapy for smoking cessationSmoking cessation interventions for smokers with current or past depressionTwo decades of smoking cessation treatment research on smokers with depression: 1990-2010The efficacy of behavioural activation treatment for co-occurring depression and substance use disorder (the activate study): a randomized controlled trialPredicted Impact of Nicotine Reduction on Smokers with Affective Disorders.Prequit fMRI responses to pleasant cues and cigarette-related cues predict smoking cessation outcome.Smiling Instead of Smoking: Development of a Positive Psychology Smoking Cessation Smartphone App for Non-daily Smokers.Behavioral activation for smoking cessation and mood management following a cardiac event: results of a pilot randomized controlled trial.Anxiety and depressive symptoms and affective patterns of tobacco withdrawal.A systematic review and meta-analysis of the effectiveness of behavioural smoking cessation interventions in selected disadvantaged groups.Integration of the brief behavioral activation treatment for depression (BATD) into a college orientation program: depression and alcohol outcomesSmoking cessation interventions for patients with depression: a systematic review and meta-analysisSubstance misuse prevention: addressing anhedoniaBAP updated guidelines: evidence-based guidelines for the pharmacological management of substance abuse, harmful use, addiction and comorbidity: recommendations from BAP.Reward and affective regulation in depression-prone smokers.Declining alternative reinforcers link depression to young adult smoking.Integrating tobacco cessation into mental health care for posttraumatic stress disorder: a randomized controlled trialAnxiety diagnoses in smokers seeking cessation treatment: relations with tobacco dependence, withdrawal, outcome and response to treatment.Implementing Behavioral Activation and Life-Steps for Depression and HIV Medication Adherence in a Community Health Center.Anxiety sensitivity mediates relations between emotional disorders and smoking.Relationship between momentary affect states and self-efficacy in adolescent smokersCognitive conflict following appetitive versus negative cues and smoking cessation failureAnxiety, depression, and cigarette smoking: a transdiagnostic vulnerability framework to understanding emotion-smoking comorbidity.A randomized controlled trial of mental health interventions for survivors of systematic violence in Kurdistan, Northern Iraq.Positive and negative reinforcement underlying risk behavior in early adolescents.Anhedonia as a component of the tobacco withdrawal syndrome.Modeling naturalistic craving, withdrawal, and affect during early nicotine abstinence: A pilot ecological momentary assessment study.Anhedonia and the relative reward value of drug and nondrug reinforcers in cigarette smokers.Effects of sequential fluoxetine and gender on prequit depressive symptoms, affect, craving, and quit day abstinence in smokers with elevated depressive symptoms: a growth curve modeling approach.Reward expectations lead to smoking uptake among depressed adolescents.Valued life activities and readiness to quit smoking among mobility-impaired smokersCigarette smoking and the onset and persistence of depression among adults in the United States: 1994-2005Valued Life Activities, Smoking Cessation, and Mood in Post-Acute Coronary Syndrome Patients.Motivation and Self-Regulation in Addiction: A Call for Convergence.The Relationship between Smoking and Depression Post-Acute Coronary Syndrome.Gender Differences in Depression: Assessing Mediational Effects of Overt Behaviors and Environmental Reward through Daily Diary MonitoringIndividual- and area-level unemployment influence smoking cessation among African Americans participating in a randomized clinical trial.Predictors of persistent nicotine dependence among adults in the United States.Rate of nicotine metabolism and smoking cessation outcomes in a community-based sample of treatment-seeking smokers.Anhedonia predicts altered processing of happy faces in abstinent cigarette smokers.
P2860
Q24186545-C66552A8-C64E-4E98-BC25-030CCA18BC43Q24200330-89EFF2B1-128C-418B-8488-934FE31171AEQ27003113-F6B127D4-C203-441A-B8C9-402A6B75AE72Q27310906-284432CA-8080-471F-8FEA-6D11F1E1507DQ30380558-AAAC5FAD-8165-4B16-9F2A-DF5F73707B05Q30577709-84BFCD89-8E5C-424B-9CF0-69A0013934BEQ33452790-281ACEA5-321D-41B0-B4CF-14EE86F3EDE9Q33568435-AF037090-1322-412E-8ECA-7AE5FAACD95CQ33725094-53A77571-C41A-4261-9ED6-3E1475BA7B42Q33871445-291FB818-D736-488E-9523-571659885AECQ33922554-D60C0780-8BB9-4316-89F4-8214F997CC2FQ34061804-AA4947A4-4B7D-4908-B979-5AEC7C9274A2Q34273749-D06FE547-52F0-4DBC-9AC1-EAFCE064CABAQ34277168-202D3429-0293-4A05-9F29-02C6D8F15297Q34294616-F71A1079-ADF3-4113-8C74-A939D0E35942Q34424807-5F94FA87-3358-49A8-8FB0-F8961B84C1F0Q34445308-5A07EAD9-D0A4-4EFD-9BD2-9C1BB444A0C0Q34472236-90E6BA8A-02B6-436B-8D48-97EFF57E3038Q34549301-129BFAA9-7F96-4C7A-9EDE-923669053AA8Q34575181-1E043106-C435-4FDC-952D-D81FFB65A56CQ34602493-164AD923-DDFB-4E2B-A715-54BE429558A7Q34842169-94B2031F-7338-4E19-B63B-2353780DAD54Q34945464-16263DEC-72AC-4AA9-B41F-63BA524CDBCFQ34992402-22C44CF7-D329-49F1-B056-EACB2A61AB47Q35109853-9B1CFF9B-08ED-4F86-9B5C-9C718528AAF4Q35142304-CF096FF4-42CE-4662-B2AC-DACA638B3934Q35298102-0A8B6D08-7149-4507-A4E2-4567812ECFA2Q35543043-2ED57ECA-9EB3-454D-9131-874744C5399BQ35596398-C7C9A517-ED0B-4B1F-A7AB-FDF193E23C85Q35624288-6EFF2BF1-A64E-427E-AEBA-A6A67B4DE5F5Q35663236-003F219F-B1EC-479A-9E16-35CA13978192Q35665999-8C50A9C1-484A-4612-970C-F3037772D8E8Q35685360-C842E7C2-DC0A-41AE-A77D-F9B7017E3343Q35703179-B5453DB8-E0DF-45E6-B757-FDE0AB37A047Q35779700-2DD0BA23-9F9E-4D61-8B78-DC2D433D3D79Q35791622-96EED9FD-C27E-45CB-8D5F-963D9FDB6A65Q35874784-54A02BE0-318A-4B7C-9FF3-5FBB856F18F8Q35915739-2A8B8737-4320-4714-B3D1-C881E4A47525Q36021256-DA09370D-6DC2-4195-B2D6-0D2C54FD41D0Q36060600-2D02CCC9-68EE-4758-8508-B9A3EE93565A
P2860
Randomized controlled trial of behavioral activation smoking cessation treatment for smokers with elevated depressive symptoms.
description
2010 nî lūn-bûn
@nan
2010 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Randomized controlled trial of ...... elevated depressive symptoms.
@ast
Randomized controlled trial of ...... elevated depressive symptoms.
@en
Randomized controlled trial of ...... elevated depressive symptoms.
@nl
type
label
Randomized controlled trial of ...... elevated depressive symptoms.
@ast
Randomized controlled trial of ...... elevated depressive symptoms.
@en
Randomized controlled trial of ...... elevated depressive symptoms.
@nl
prefLabel
Randomized controlled trial of ...... elevated depressive symptoms.
@ast
Randomized controlled trial of ...... elevated depressive symptoms.
@en
Randomized controlled trial of ...... elevated depressive symptoms.
@nl
P2093
P2860
P356
P1476
Randomized controlled trial of ...... elevated depressive symptoms.
@en
P2093
Alexis K Matusiewicz
C W Lejuez
Christopher W Kahler
David R Strong
Derek R Hopko
Laura MacPherson
Richard A Brown
Samantha Rodman
P2860
P356
10.1037/A0017939
P577
2010-02-01T00:00:00Z